Generally, the prognosis for dengue is considered good when immediate diagnosis and

appropriate treatment are carried out. Dengue is a mosquito-borne infection that may
lead to a severe flu-like illness, and no specific therapeutic agents were found for this
disease. In less than 1 percent of cases, typical dengue infection is fatal. The worst
symptoms may occur in patients with dengue for about 1 to 2 weeks, and recovery from
the disease is usually achieved after several weeks (Cunha, J. 2021). Dengue may be
anticipated after 5–7 days of incubation period, and the course has three (3) phases:
febrile, critical, and convalescent. In febrile phase of dengue, the patient would
experience fever for 2-7 days, and this fever can be biphasic. There may be warning
signs during the time of defervescence in the late febrile phase that severity of dengue
has progressed, and symptoms should be observed closely. Critical phase, on the other
hand, would normally last for 24-48 hours, and starts at defervesence. During this
phase, most patients are noticed to have therapeutically improved. However, severe
dengue may develop in patients with substantial plasma leakage witihin a few hours due
to marked increase in vascular permeability. Hemorrhagic manifestations, including
hematemesis, bloody stool, or menorrhagia may also be developed especially if they
were in a prolonged shock. Lastly, convalescent stage, this is where extravasated
intravenous fluids and pleural and abdominal effusions ss plasma leakage diminishes
(Centers for Disease Control and Prevention, 2021).

Although most people recover from this disease, hemorrhagic manifestations may
appear often in patients from mild to severe, and these contribute to dengue mortality
and morbidity. The prognosis for dengue infection may be possibly abysmal when
patients are left untreated, and have no supportive care (Nujum, Z. T. 2019). Without
treatment, it may possibly lead to a fatal complication they refer to as dengue
hemorrhagic fever (DFH). This form of illness is fatal in 2.5 percent of cases, and
mortality rates can be as high as 20%-50% especially in children. Patients with DFH
must be monitored for the first few days since there is a possibility that it can be
followed by dengue shock syndrome (DSS). This shock syndrome is claimed to be the
most severe form of the illness. Practically 20-40 percent of DFH cases lead to dengue
shock syndrome, and 40-50 percent of patients who have experienced this die of DSS.
In most cases, death that occurs in children appears as a consequence of dengue
shock syndrome (Khan, K. & Bhutta, Z. 2017). Particular treatment may not exist but
patients can recover from this with a good supportive care, and medical treatment that
can vastly decrease the mortality rates.

Schaefer, T. J., Panda, P. K., Wolford, R. W. (2021). Dengue Fever. Retrieved from
https://www.ncbi.nlm.nih.gov/books/NBK430732/#article-20347.s10

Cunha, J. P. (2021). Dengue Fever. Retrieved from

https://www.medicinenet.com/dengue_fever/article.htm

Science Direct. (n.d). Severe Dengue. Retrieved from

https://www.sciencedirect.com/topics/medicine-and-dentistry/severe-dengue

Centers for Disease Control and Prevention. (2021). Clinical Presentation. Retrieved
from https://www.cdc.gov/dengue/healthcare-providers/clinical-presentation.html